Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer. Founded in 2017, Navrogen is backed by investors that include and is headquartered in Philadelphia.
FOUNDED:
2017
INDUSTRY:
Biotechnology, Life Science, Pharmaceutical
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
